Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The role of the hepatitis c pharmacist in managing complex drug-drug interactions
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: TORKINGTON, Adele (NORTH WEST ID UNIT @ NORTH MANCHESTER GENERAL HOSPITAL, Mrs)
- Co-author(s): Adele Marie Torkington
BackgroundDirectly active antivirals (DAA’s) are highly effective to cure Hepatitis C (HCV). However HCV patients have co-morbidities which complicate the most cost effective treatment of HCV as the DAA’s have many drug-drug interactions (DDIs) It is recommended that co-medicines are assessed for DDI before and during treatment. Clinical.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 13 May 2019